Egf family ligands

The Cytokine Handbook

Volumn , Issue , 2003, Pages 959-987

  Lee, David C ^a   Hinkle, C Leann ^a   Jackson, Leslie F ^a   Li, Shunqiang ^a   Sunnarborg, Susan Wohler ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038414842     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/B978-012689663-3/50045-4     Document Type: Chapter

References (334)

1. Abraham J.A., Damm D., Bajardi A., et al. Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun. 1993, 190:125-133.
2. Adam R., Drummond D.R., Solic N., et al. Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. Biochim. Biophys. Acta 1995, 1266:83-90.
3. Alimandi M., Wang L.M., Bottaro D., et al. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J. 1997, 16:5608-5617.
4. Alroy I., Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 1997, 410:83-86.
5. Amundadottir L.T., Nass S.J., Berchem G.J., et al. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene 1996, 13:757-765.
6. Anklesaria P., Teixido J., Laiho M., et al. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc. Natl. Acad. Sci. USA 1990, 87:3289-3293.
7. Anzano M.A., Roberts A.B., Meyers C.A., et al. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 1982, 42:4776-4778.
8. Arkonac B.M., Foster L.C., Sibinga N.E., et al. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. J. Biol. Chem. 1998, 273:4400-4405.
9. Arribas J., Massague J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J. Cell. Biol. 1995, 128:433-441.
10. Arribas J., Coodly L., Vollmer P., et al. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 1996, 271:11376-11382.
11. Arribas J., Lopez-Casillas F., Massague J. Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. J. Biol. Chem. 1997, 272:17160-17165.
12. Asakura M., Kitakaze M., Takashima S., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8:35-40.
13. Baba I., Shirasawa S., Iwamoto R., et al. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res. 2000, 60:6886-6889.
14. Barnard J.A., Graves-Deal R., Pittelkow M.R., et al. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 1994, 269:22817-22822.
15. Barrow L.L., Simin K., Jones J.M., et al. Conserved linkage of early growth response 4, annexin 4, and transforming growth factor alpha on mouse chromosome 6. Genomics 1994, 19:388-390.
16. Baselga J., Mendelsohn J., Kim Y.M., Pandiella A. Autocrine regulation of membrane transforming growth factor-alpha cleavage. J. Biol. Chem. 1996, 271:3279-3284.
17. Bastian S.E., Dunbar A.J., Priebe I.K., et al. Measurement of betacellulin levels in bovine serum, colostrum and milk. J. Endocrinol. 2001, 168:203-212.
18. Beerli R.R., Hynes N.E. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 1996, 271:6071-6076.
19. Bell G.I., Fong N.M., Stempien M.M., et al. Human epidermal growth factor precursor: cDNA sequences expression in vitro and gene organization. Nucleic Acids Res. 1986, 14:8427-8446.
20. Berkowitz E.A., Hissong M.A., Lee D.C. Transcriptional and post-transcriptional induction of the TGFalpha gene in transformed rat liver epithelial cells. Oncogene 1996, 12:1991-2002.
21. Berkowitz E.A., Seroogy K.B., Schroeder J.A., et al. Characterization of the mouse transforming growth factor alpha gene: its expression during eyelid development and in waved 1 tissues. Cell Growth Differ. 1996, 7:1271-1282.
22. Berkowitz E.A., Hecht C.P., Azizkhan J.C., et al. Transcription factor AP2 is required for expression of the rat transforming growth factor-alpha gene. Oncogene 1997, 14:2229-2238.
23. Besner G., Higashiyama S., Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1990, 1:811-819.
24. Black R.A. Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell. Biol. 2002, 34:1-5.
25. Blasband A.J., Gilligan D.M., Winchell L.F., et al. Expression of the TGF alpha integral membrane precursor induces transformation of NRK cells. Oncogene 1990, 5:1213-1221.
26. Blasband A.J., Rogers K.T., Chen X.R., et al. Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences. Mol. Cell. Biol. 1990, 10:2111-2121.
27. Bockman D.E., Merlino G. Cytological changes in the pancreas of transgenic mice overexpressing trans-forming growth factor alpha. Gastroenterology 1992, 103:1883-1892.
28. Boillee S., Cadusseau J., Coulpier M., et al. Transforming growth factor alpha: a promoter of motoneuron survival of potential biological relevance. J. Neurosci. 2001, 21:7079-7088.
29. Bosenberg M.W., Pandiella A., Massague J. Activated release of membrane-anchored TGF-alpha in the absence of cytosol. J. Cell. Biol. 1993, 122:95-101.
30. Brachmann R., Lindquist P.B., Nagashima M., et al. Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell 1989, 56:691-700.
31. Briley G.P., Hissong M.A., Chiu M.L., Lee D.C. The carboxyl-terminal valine residues of proTGF alpha are required for its efficient mutation and intracellular routing. Mol. Biol. Cell. 1997, 8:1619-1631.
32. Bringman T.S., Lindquist P.B., Derynck R. Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell 1987, 48:429-440.
33. Brissenden J.E., Ullrich A., Francke U. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature 1984, 310:781-784.
34. Brown C.L., Meise K.S., Plowman G.D., et al. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J. Biol. Chem. 1998, 273:17258-17268.
35. Brown C.L., Coffey R.J., Dempsey P.J. The proamphiregulin cytoplasmic domain is required for basolateral sorting, but is not essential for constitutive or stimulus-induced processing in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 2001, 276:29538-29549.
36. Brown P.I., Lam R., Lakshmanan J., Fisher D.A. Transforming growth factor alpha in developing rats. Am. J. Physiol. 1990, 259:E256-E260.
37. Bursi R., Sawa M., Hiramatsu Y., Kondo H. A three-dimensional quantitative structure-activity relationship study of heparin-binding epidermal growth factor shedding inhibitors using comparative molecular field analysis. J. Med. Chem. 2002, 45:781-788.
38. Carpenter G., Wahl M.I. The epidermal growth factor family. Peptide Growth Factors and Their Receptors I 1990, 69-171. Springer-Verlag, Berlin. A.B. Roberts (Ed.).
39. Carraway K.L., Weber J.L., Unger M.J., et al. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 1997, 387:512-516.
40. Chen X., Wright K.L., Berkowitz E.A., et al. Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting. Oncogene 1994, 9:3179-3187.
41. Chen X., Raab G., Deutsch U., et al. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J. Biol. Chem. 1995, 270:18285-18294.
42. Ciardiello F., Kim N., Saeki T., et al. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. USA 1991, 88:7792-7796.
43. Coffey R.J., Derynck R., Wilcox J.N., et al. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature 1987, 328:817-820.
44. Coffey R.J., Meise K.S., Matsui Y., et al. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res. 1994, 54:1678-1683.
45. Cohen S. Purification of a nerve-growth promoting protein from the mouse salivary gland and its neurocytotoxic antiserum. Proc. Natl Acad. Sci. USA 1960, 46:302-311.
46. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 1962, 237:1555-1562.
47. Cohen S. The stimulation of epidermal proliferation by a specific protein (EGF). Dev. Biol. 1965, 12:394-407.
48. Cohen S., Elliot G. The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. J. Invest. Dermatol. 1963, 40:1-5.
49. Cook P.W., Mattox P.A., Keeble W.W., et al. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol. Cell. Biol. 1991, 11:2547-2557.
50. Cook P.W., Mattox P.A., Keeble W.W., Shipley G.D. Inhibition of autonomous human keratinocyte proliferation and amphiregulin mitogenic activity by sulfated polysaccharides. In Vitro Cell. Dev. Biol. 1992, 28A:218-222.
51. Cook P.W., Pittelkow M.R., Keeble W.W., et al. Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res. 1992, 52:3224-3227.
52. Cooke R.M., Wilkinson A.J., Baron M., et al. The solution structure of human epidermal growth factor. Nature 1987, 327:339-341.
53. Cozzolino M., Lu Y., Finch J., et al. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 2001, 60:2109-2117.
54. Cribbs R.K., Harding P.A., Luquette M.H., Besner G.E. Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J. Burn Care Rehabil. 2002, 23:116-125.
55. Daly J.M., Olayioye M.A., Wong A.M., et al. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumor cells: role of PI3 kinase and p38 MAP kinase pathways. Oncogene 1999, 18:3440-3451.
56. Das S.K., Wang X.N., Paria B.C., et al. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a prossible ligand for interaction with blastocyst EGF-receptor in implantation. Development 1994, 120:1071-1083.
57. Das S.K., Das N., Wang J., et al. Expression of beta-cellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the ’window’ of implantation. Dev. Biol. 1997, 190:178-190.
58. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379:557-560.
59. Decsi A., Peiffer R.L., Qiu T., et al. Lens expression of TGF alpha in transgenic mice produces two distinct eye pathologies in the absence of tumors. Oncogene 1994, 9:1965-1975.
60. de Larco J.E., Todaro G.J. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl Acad. Sci. USA 1978, 75:4001-4005.
61. Dempsey P.J., Goldenring J.R., Soroka C.J., et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology 1992, 103:1950-1963.
62. Dempsey P.J., Coffey R.J. Basolateral targeting and efficient consumption of transforming growth factor-alpha when expressed in Madin-Darby canine kidney cells. J. Biol. Chem. 1994, 269:16878-16889.
63. Derynck R., Roberts A.B., Winkler M.E., et al. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell 1984, 38:287-297.
64. Derynck R., Roberts A.B., Eaton D.H., et al. Human transforming growth factor-α: precursor sequence, gene structure, and heterologous expression. Cancer Cells 1985, 3:79-86.
65. Dethlefsen S.M., Raab G., Moses M.A., et al. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J. Cell Biochem. 1998, 69:143-153.
66. De Vos J., Couderc G., Tarte K., et al. Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays. Blood 2001, 98:771-780.
67. Dluz S.M., Higashiyama S., Damm D, et al. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 1993, 268:18330-18334.
68. Dobashi Y., Stern D.F. Membrane-anchored forms of EGF stimulate focus formation and intercellular communication. Oncogene 1991, 6:1151-1159.
69. Dong J., Opresko L.K., Dempsey P.J., et al. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc. Natl Acad. Sci. USA 1999, 96:6235-6240.
70. Downing M.T., Brigstock D.R., Luquette M.H., et al. Immunohistochemical localization of heparin-binding epidermal growth factor-like growth factor in normal skin and skin cancers. Histochem. J. 1997, 29:735-744.
71. Dunbar A.J., Goddard C. Structure-function and biological role of betacellulin. Int. J. Biochem. Cell. Biol. 2000, 32:805-815.
72. Dunbar A.J., Priebe I.K., Belford D.A., Goddard C. Identification of betacellulin as a major peptide growth factor in milk: purification, characterization and molecular cloning of bovine betacellulin. Biochem. J. 1999, 344(Pt 3):713-721.
73. Dusso A.S., Pavlopoulos T., Naumovich L., et al. p21 (WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int. 2001, 59:855-865.
74. Ebert M., Yokoyama M., Kobrin M.S., et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res. 1994, 54:3959-3962.
75. Ebner R., Derynck R. Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul. 1991, 2:599-612.
76. Elenius K., Paul S., Allison G., et al. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997, 16:1268-1278.
77. Ellis P.D., Hadfield K.M., Pascall J.C., Brown K.D. Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen-activated protein kinase cascades. Biochem. J. 2001, 354:99-106.
78. Factor V.M., Kiss A., Woitach J.T., et al. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J. Biol. Chem. 1998, 273:15846-15853.
79. Fan H., Derynck R. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 1999, 18:6962-6972.
80. Fang Y., Sheffield L.G. Regulation of epidermal growth factor expression in mammary epithelial cells by a Yin-Yang-1-like element. J. Mol. Endocrinol. 1998, 20:337-344.
81. Fen Z., Dhadly M.S., Yoshizumi M., et al. Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor. Biochemistry 1993, 32:7932-7938.
82. Fenton S.E., Groce N.S., Lee D.C. Characterization of the mouse epidermal growth factor promoter and 5’-flanking region. Role for an atypical TATA sequence. J. Biol. Chem. 1996, 271:30870-30878.
83. Fernandes A.M., Hamburger A.W., Gerwin B.I. Production of epidermal growth factor related ligands in tumorigenic and benign human lung epithelial cells. Cancer Lett. 1999, 142:55-63.
84. Fernandez-Larrea J., Merlos-Suarez A., Urena J.M., et al. A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface. Mol. Cell. 1999, 3:423-433.
85. Fowler K.J., Mann G.B., Dunn A.R. Linkage of the murine transforming growth factor alpha gene with Igk, Ly-2, and Fabpl on chromosome 6. Genomics 1993, 16:782-784.
86. Fowler K.J., Walker F., Alexander W., et al. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl Acad. Sci. USA 1995, 92:1465-1469.
87. Fujino T., Hasebe N., Fujita M., et al. Enhanced expression of heparin-binding EGF-like growth factor and its receptor in hypertrophied left ventricle of spontaneously hypertensive rats. Cardiovasc. Res. 1998, 38:365-374.
88. Gechtman Z., Alonso J.L., Raab G., et al. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 1999, 274:28828-28835.
89. Gentry L.E., Twardzik D.R., Lim G.J., et al. Expression and characterization of transforming growth alpha precursor protein in transfected mammalian cells. Mol. Cell. Biol. 1987, 7:1585-1591.
90. Ghanem M.A., van Der Kwast T.H., Den Hollander J.C., et al. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma. Cancer 2001, 92:3120-3129.
91. Goishi K., Higashiyama S., Klagsbrun M., et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell. 1995, 6:967-980.
92. Graus-Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. Embo. J. 1997, 16:1647-1655.
93. Gray A., Dull T.J., Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 1983, 303:722-725.
94. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975, 257:325-327.
95. Greslik E.W., Gubits R.M., Barka T. In situ localization of mRNA for epidermal growth factor in the submandibular gland of the mouse. J. Histochem. Cytochem. 1985, 33:1235-1240.
96. Groenen L.C., Nice E.E., Burgess A.W. Structure-function relationship for the EGF/TGFα family of mitogens. Growth Factors 1994, 11:235-257.
97. Guy P.M., Platko J.V., Cantley L.C., et al. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA 1994, 91:8132-8136.
98. Han V.K., Hunter E.S., Pratt R.M., et al. Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua. Mol. Cell. Biol. 1987, 7:2335-2343.
99. Harari D., Tzahar E., Romano J., et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 1999, 18:2681-2689.
100. Harding P.A., Brigstock D.R., Shen L., et al. Characterization of the gene encoding murine heparin-binding epidermal growth factor-like growth factor. Gene 1996, 169:291-292.
101. Harding P.A., Davis-Fleischer K.M., Crissman-Combs M.A., Miller M.T., Brigstock D.R., Besner G.E. Induction of anchorage independent growth by heparin-binding EGF-like growth factor (HB-EGF). Growth Factors 1999, 17:49-61.
102. Hashimoto K. Regulation of keratinocyte function by growth factors. J. Dermatol. Sci. 2000, 24(Suppl. 1):S46-S50.
103. Hashimoto K., Higashiyama S., Asada H., et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 1994, 269:20060-20066.
104. Hasuwa H., Shishido Y., Yamazaki A., et al. CD9 amino acids critical for upregulation of diphtheria toxin binding. Biochem. Biophys. Res. Commun. 2001, 289:782-790.
105. Hibbert S.A., Field J.K. Molecular basis of familial cleft lip and palate. Oral Dis. 1996, 2:238-241.
106. Higashiyama S., Abraham J.A., Miller J., et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991, 251:936-939.
107. Higashiyama S., Lau K., Besner G.E., et al. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 1992, 267:6205-6212.
108. Higashiyama S., Abraham J.A., Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell. Biol. 1993, 122:933-940.
109. Higashiyama S., Iwamoto R., Goishi K., et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell. Biol. 1995, 128:929-938.
110. Holladay L.A., Savage C.R., Cohen S., Puett D. Conformation and unfolding thermodynamics of epidermal growth factor and derivatives. Biochemistry 1976, 15:2624-2633.
111. Hommel U., Harvey T.S., Driscoll P.C., Campbell I.D. Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha. J. Mol. Biol. 1992, 227:271-282.
112. Howell G.M., Humphrey L.E., Awwad R.A., et al. Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells. J. Biol. Chem. 1998, 273:9214-9223.
113. Howell G.M., Humphrey L.E., Ziober B.L., et al. Regulation of transforming growth factor alpha expression in a growth factor-independent cell line. Mol. Cell. Biol. 1998, 18:303-313.
114. Humphreys R.C., Hennighausen L. Transforming growth factor alpha and mouse models of human breast cancer. Oncogene 2000, 19:1085-1091.
115. Huotari M.A., Palgi J., Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology 1998, 139:1494-1499.
116. Ignotz R.A., Kelly B., Davis R.J., Massague J. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proc. Natl Acad. Sci. USA 1986, 83:6307-6311.
117. Inui Y., Higashiyama S., Kawata S., et al. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma. Gastroenterology 1994, 107:1799-1804.
118. Ito Y., Higashiyama S., Takeda T., et al. Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma. Int. J. Pancreatol. 2001, 29:47-52.
119. Ito Y., Takeda T., Higashiyama S., et al. Expression of heparin-binding epidermal growth factor-like growth factor in breast carcinoma. Breast Cancer Res. Treat. 2001, 67:81-85.
120. Iwamoto R., Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 2000, 11:335-344.
121. Iwamoto R., Senoh H., Okada Y., et al. An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor. J. Biol. Chem. 1991, 266:20463-20469.
122. Iwamoto R., Higashiyama S., Mitamura T., et al. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994, 13:2322-2330.
123. Iwamoto R., Handa K., Mekada E. Contact-dependent growth factor inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem. 1999, 274:25906-25912.
124. Izumi Y., Hirata M., Hasuwa H., et al. A metallo-protease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998, 17:7260-7272.
125. Jakobovits E.B., Schlokat U., Vannice J.L., et al. The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence. Mol. Cell. Biol. 1988, 8:5549-5554.
126. Jhappan C., Stahle C., Harkins R.N., et al. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61:1137-1146.
127. Jhappan C., Takayama H., Dickson R.B., Merlino G. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumori-genesis via H-ras-dependent and H-ras-independent pathways. Cell. Growth Differ. 1994, 5:385-394.
128. Jiang D., Liang J., Humphrey L.E., et al. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor. J. Cell. Physiol. 1998, 175:174-183.
129. Johnson G.R., Wong L. Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J. Biol. Chem. 1994, 269:27149-27154.
130. Johnson G.R., Saeki T., Gordon A.W., et al. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J. Cell. Biol. 1992, 118:741-751.
131. Johnson G.R., Kannan B., Shoyab M., Stromberg K. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J. Biol. Chem. 1993, 268:2924-2931.
132. Johnson G.R., Prigent S.A., Gullick W.J., Stromberg K. Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity. J. Biol. Chem. 1993, 268:18835-18843.
133. Johnson S.E., Rothstein J.L., Knowles B.B. Expression of epidermal growth factor family gene members in early mouse development. Dev. Dyn. 1994, 201:216-226.
134. Jones J.T., Akita R.W., Sliwkowski M.X. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 1999, 447:227-231.
135. Junier M.P. What role(s) for TGFalpha in the central nervous system?. Prog. Neurobiol. 2000, 62:443-473.
136. Kallincos N.C., Xian C.J., Dunbar A.J., et al. Cloning of rat batacellulin and characterization of its expression in the gastrointestinal tract. Growth Factors 2000, 18:203-213.
137. Kalmes A., Vesti B.R., Daum G., et al. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ. Res. 2000, 87:92-98.
138. Kawaguchi M., Hosotani R., Kogire M., et al. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Int. J. Oncol. 2000, 16:37-41.
139. Kenney N.J., Huang R.P., Johnson G.R., et al. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol. Reprod. Dev. 1995, 41:277-286.
140. Kenney N.J., Smith G.H., Maroulakou I.G., et al. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol. Carcinog. 1996, 15:44-56.
141. Kenney N.J., Smith G.H., Rosenberg K., et al. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell. Growth Differ. 1996, 7:1769-1781.
142. Kim G.Y., Besner G.E., Steffen C.L., et al. Purification of heparin-binding epidermal growth factor-like growth factor from pig uterine luminal flushings, and its production by endometrial tissues. Biol. Reprod. 1995, 52:561-571.
143. Kim I., Mogford J.E., Chao J.D., Mustoe T.A. Wound epithelialization deficits in the transforming growth factor-alpha knockout mouse. Wound Repair Regen. 2001, 9:386-390.
144. Kimura H., Fischer W.H., Schubert D. Structure expression and function of a Schwannoma-derived growth factor. Nature 1990, 348:257-260.
145. Kitadai Y., Yasui W., Yokozaki H., et al. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas. Jpn J. Cancer Res. 1993, 84:879-884.
146. Knebelmann B., Ananth S., Cohen H.T., Sukhatme V.P. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res. 1998, 58:226-231.
147. Kohda D., Go N., Hayashi K., Inagaki F. Tertiary structure of mouse epidermal growth factor determined by two-dimensional 1H NMR. J. Biochem. (Tokyo) 1988, 103:741-743.
148. Komurasaki T., Toyoda H., Uchida D., Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 1997, 15:2841-2848.
149. Korfhagen T.R., Swantz R.J., Wert S.E., et al. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenice mice. J. Clin. Invest. 1994, 93:1691-1699.
150. Kornblum H.I., Zurcher S.D., Werb Z., et al. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur. J. Neurosci. 1999, 11:3236-3246.
151. Krakowski M.L., Kritzik M.R., Jones E.M., et al. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J. Endocrinol. 1999, 162:167-175.
152. Kramer A., Yang F.C., Snodrass P., et al. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 2001, 294:2511-2515.
153. Kuo A., Zhong C., Lane W.S., Derynck R. Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55. EMBO J. 2000, 19:6427-6439.
154. Lakshmanan J., Eysselein V. Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney disease. Biochem. Biophys. Res. Commun. 1993, 197:1083-1093.
155. Lanzrein M., Garred O., Olsnes S., Sandvig K. Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): studies on the cell-associated receptor cleaved by a metalloprotease in phorbol-ester-treated cells. Biochem. J. 1995, 310:285-289.
156. Leach R.E., Khalifa R., Ramirez N.D., et al. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrical cycle and early placentation. J. Clin. Endocrinol. Metab. 1999, 84:3355-3363.
157. Lee D.C., Rose T.M., Webb N.R., Todaro G.J. Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Nature 1985, 313:489-491.
158. Lee D.C., Fenton S.E., Berkowitz E.A., Hissong M.A. Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol. Rev. 1995, 47:51-85.
159. Lee S.B., Huang K., Palmer R., et al. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 1999, 98:663-673.
160. Lemjabbar H., Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcusaureusin epithelial cells. Nat. Med. 2002, 8:41-46.
161. Lemmon M.A., Bu Z., Ladbury J.E., et al. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 1997, 16:281-294.
162. Levi-Montalcini R.C.S. Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals. Ann. NY Acad Sci. 1960, 85:324-341.
163. Li S., Plowman G.D., Buckley S.D., Shipley G.D. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell. Physiol. 1992, 153:103-111.
164. Liu C., Woo A., Tsao M.S. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br. J. Cancer 1990, 62:425-429.
165. Lu H.S., Chai J.J., Li M., et al. Crystal structure of human epidermal growth factor and its dimerization. J. Biol. Chem. 2001, 276:34913-34917.
166. Luetteke N.C., Michalopoulos G.K., Teixido J., et al. Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells. Biochemistry 1988, 27:6487-6494.
167. Luetteke N.C., Lee D.C., Palmiter R.D., et al. Regulation of fat and muscle development by transforming growth factor alpha in transgenic mice and in cultured cells. Cell Growth Differ. 1993, 4:203-213.
168. Luetteke N.C., Qiu T.H., Peiffer R.L., et al. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993, 73:263-278.
169. Luetteke N.C., Phillips H.K., Qiu T.H., et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 1994, 8:399-413.
170. Luetteke N.C., Qiu T.H., Fenton S.E., et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999, 126:2739-2750.
171. Lysiak J.J., Johnson G.R., Lala P.K. Localization of amphiregulin in the human placenta and decidua throughout gestation: role in trophoblast growth. Placenta 1995, 16:359-366.
172. Ma L., Gauville C., Berthois Y., et al. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line. Oncogene 1999, 18:6513-6520.
173. Machida J., Yoshiura K., Funkhauser C.D., et al. Transforming growth factor-alpha (TGFA): genomic structure, boundary sequences, and mutation analysis in nonsyndromic cleft lip/palate and cleft palate only. Genomics 1999, 61:237-242.
174. Mann G.B., Fowler K.J., Gabriel A., et al. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993, 73:249-261.
175. Marquardt H., Hunkapiller M.W., Hood L.E., Todaro G.J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 1984, 223:1079-1082.
176. Marques S.A., Dy L.C., Southall M.D., et al. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J. Pharmacol. Exp. Ther. 2002, 300:1026-1035.
177. Martinez-Lacaci I., Johnson G.R., Salomon D.S., Dickson R.B. Characterization of a novel amphiregulin-related molecule in 12-O-tetradecanoylphorbol-13-acetate-treated breast cancer cells. J. Cell. Physiol. 1996, 169:497-508.
178. Mashima H., Ohnishi H., Wakabayashi K., et al. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 1996, 97:1647-1654.
179. Mashima H., Yamada S., Tajima T., et al. Genes expressed during the differentiation of pancreatic AR42J cells into insulin-secreting cells. Diabetes 1999, 48:304-309.
180. Massague J. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J. Biol. Chem. 1983, 258:13614-13620.
181. Massague J., Pandiella A. Membrane-anchored growth factors. Annu. Rev. Biochem. 1993, 62:515-541.
182. Matsui Y., Halter S.A., Holt J.T., et al. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 1990, 61:1147-1155.
183. McAndrew J., Paterson A.J., Asa S.L., et al. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 1995, 136:4479-4488.
184. McCarthy S.A., Samuels M.L., Pritchard C.A., et al. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 1995, 9:1953-1964.
185. McCarthy S.A., Yang B.S., et al. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 1997, 17:2401-2412.
186. McInnes C., Hoyt D.W., Harkins R.N., et al. NMR study of the transforming growth factor-alpha (TGF-alpha)-epidermal growth factor receptor complex. Visualization of human TGF-alpha binding determinants through nuclear Overhauser enhancement analysis. J. Biol. Chem. 1996, 271:32204-32211.
187. McInnes C., Wang J., Al Moustafa A.E., et al. Structure-based minimization of transforming growth factor-alpha (TGF-alpha) through NMR analysis of the receptor-bound ligand. Design, solution structure, and activity of TGF-alpha 8-50. J. Biol. Chem. 1998, 273:27357-27363.
188. McInnes C., Grothe S., O’Connor-McCourt M., Sykes B.D. NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor. Prot. Eng. 2000, 13:143-147.
189. Merlos-Suarez A., Ruiz-Paz S., Baselga J., Arribas J. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J. Biol. Chem. 2001, 276:48510-48517.
190. Michalsky M.P., Lara-Marquez M., Chun L., Besner G.E. Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk. J. Pediatr. Surg. 2002, 37:1-6.
191. Miettinen P.J., Berger J.E., Meneses J., et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995, 376:337-341.
192. Miettinen P.J., Chin J.R., Shum L., et al. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat. Genet. 1999, 22:69-73.
193. Mitamura T., Iwamoto R., Umata T., et al. The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J. Cell. Biol. 1992, 118:1389-1399.
194. Miyagawa J., Higashiyama S., Kawata S., et al. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 1995, 95:404-411.
195. Miyagawa J., Hanafusa O., Sasada R., et al. Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocr. J. 1999, 46:755-764.
196. Miyoshi E., Higashiyama S., Nakagawa T., et al. Membrane-anchored heparin-binding epidermal growth factor-like growth factor acts as a tumor survival factor in a hepatoma cell line. J. Biol. Chem. 1997, 272:14349-14355.
197. Modrell B., McDonald V.L., Shoyab M. The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins. Growth Factors 1992, 7:305-314.
198. Montelione G.T., Wuthrich K., Nice E.C., et al. Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry. Proc. Natl Acad. Sci. USA 1987, 84:5226-5230.
199. Montelione G.T., Winkler M.E., Burton L.E., et al. Sequence-specific 1H-NMR assignments and identification of two small antiparallel beta-sheets in the solution structure of recombinant human transforming growth factor alpha. Proc. Natl Acad. Sci. USA 1989, 86:1519-1523.
200. Montelione G.T., Wuthrich K., Burgess A.W., et al. Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. Biochemistry 1992, 31:236-249.
201. Morton C.C., Byers M.G., Nakai H., et al. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet. Cell. Genet. 1986, 41:245-249.
202. Mroczkowski B., Reich M., Whittaker J., et al. Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 1988, 85:126-130.
203. Mroczkowski B., Reich M., Chen K., et al. Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Mol. Cell. Biol. 1989, 9:2771-2778.
204. Murakami H., Sanderson N.D., Nagy P., et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 1993, 53:1719-1723.
205. Murayama Y., Miyagawa J., Higashiyama S., et al. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology 1995, 109:1051-1059.
206. Nakagawa T., Sasahara M., Hayase Y., et al. Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat. Brain Res. Dev. Brain Res. 1998, 108:263-272.
207. Nakamura K., Iwamoto R., Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell. Biol. 1995, 129:1691-1705.
208. Nakamura K., Mitamura T., Takahashi T., et al. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J. Biol. Chem. 2000, 275:18284-18290.
209. Nakamura Y., Handa K., Iwamoto R., et al. Immunohistochemical distribution of CD9, heparin binding epidermal growth factor-like growth factor, and integrin alpha3beta1 in normal human tissues. J. Histochem. Cytochem. 2001, 49:439-444.
210. Nishi E., Prat A., Hospital V., Elenius K., Klagsbrun M. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J. 2001, 20:3342-3350.
211. Nishida M., Miyagawa J., Yamashita S., et al. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1236-1243.
212. Normanno N., Selvam M.P., Qi C.F., et al. Amphi-regulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Proc. Natl Acad. Sci. USA 1994, 91:2790-2794.
213. Normanno N., Bianco C., De Luca A., Salomon D.S. The role of EGF-related peptides in tumor growth. Front. Biosci. 2001, 6:D685-D707.
214. Opanashuk L.A., Mark R.J., Porter J., et al. Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action. J. Neurosci. 1999, 19:133-146.
215. Ouchi N., Kihara S., Yamashita S., et al. Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages. Biochem. J. 1997, 328:923-928.
216. Pandiella A., Massague J. Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process. Proc. Natl Acad. Sci. USA 1991, 88:1726-1730.
217. Pandiella A., Massague J. Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. J. Biol. Chem. 1991, 266:5769-5773.
218. Paria B.C., Elenius K., Klagsbrun M., Dey S.K. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation. Development 1999, 126:1997-2005.
219. Pascall J.C., Brown K.D. Identification of a minimal promoter element of the mouse epidermal growth factor gene. Biochem. J. 1997, 324:869-875.
220. Pascall J.C., Surani M.A., Barton S.C., et al. Directed expression of simian virus 40 T-antigen in transgenic mice using the epidermal growth factor gene promoter. J. Mol. Endocrinol. 1994, 12:313-325.
221. Pathak B.G., Gilbert D.J., Harrison C.A., et al. Mouse chromosomal location of three EGF receptor ligands: amphiregulin (Areg), betacellulin (Btc), and heparin-binding EGF (Hegfl). Genomics 1995, 28:116-118.
222. Peoples G.E., Blotnick S., Takahashi K., et al. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc. Natl Acad. Sci. USA 1995, 92:6547-6551.
223. Perrella M.A., Maki T., Prasad S., et al. Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J. Biol. Chem. 1994, 269:27045-27050.
224. Peschon J.J., Slack J.L., Reddy P., et al. An essential role for ectodomain shedding in mammalian development. Science 1998, 282:1281-1284.
225. Piepkorn M., Lo C., Plowman G. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell. Physiol. 1994, 159:114-120.
226. Pike L.J., Marquardt H., Todaro G.J., et al. Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner. J. Biol. Chem. 1982, 257:14628-14631.
227. Pinkas-Kramarski R., Lenferink A.E., Bacus S.S., et al. The oncogenic Erbb-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene 1998, 16:1249-1258.
228. Plowman G.D., Green J.M., McDonald V.L., et al. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol. Cell. Biol. 1990, 10:1969-1981.
229. Prenzel N., Zwick E., Daub H., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
230. Qi C.F., Liscia D.S., Normanno N., et al. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Br. J. Cancer 1994, 69:903-910.
231. Raab G., Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1997, 1333:F179-F199.
232. Rage F., Hill D.F., Sena-Esteves M., et al. Targeting transforming growth factor alpha expression to discrete loci of the neuroendocrine brain induces female sexual precocity. Proc. Natl Acad. Sci. USA 1997, 94:2735-2740.
233. Rall L.B., Scott J., Bell G.I., et al. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 1985, 313:228-231.
234. Rappolee D.A., Brenner C.A., Schultz R., et al. Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos. Science 1988, 241:1823-1825.
235. Richter A., Drummond D.R., MacGravie J., et al. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor. J. Biol. Chem. 1995, 270:1612-1616.
236. Riese D.J., van Raaij T.M., Plowman G.D., et al. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 1995, 15:5770-5776.
237. Riese D.J., Bermingham Y., van Raaij T.M., et al. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 1996, 12:345-353.
238. Riese D.J., Kim E.D., Elenius K., et al. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 1996, 271:20047-20052.
239. Riese D.J., Komurasaki T., Plowman G.D., Stern D.F. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J. Biol. Chem. 1998, 273:11288-11294.
240. Roberts A.B., Lamb L.C., Newton D.L., et al. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl Acad. Sci. USA 1980, 77:3494-3498.
241. Roberts A.B., Anzano M.A., Lamb L.C., et al. Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature 1982, 295:417-419.
242. Russell W.E., Kaufmann W.K., Sitaric S., et al. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol. Carcinog. 1996, 15:183-189.
243. Saeki T., Stromberg K., Qi C.F., et al. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res. 1992, 52:3467-3473.
244. Sandgren E.P., Luetteke N.C., Palmiter R.D., et al. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990, 61:1121-1135.
245. Sandgren E.P., Schroeder J.A., Qui T.H., et al. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 1995, 55:3915-3927.
246. Santoni-Rugiu E., Jensen M.R., Thorgeirsson S.S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res. 1998, 58:123-134.
247. Sasada R., Igarashi K. Betacellulin: a new growth factor for vascular smooth muscle cells. Nippon Rinsho 1993, 51:3308-3317.
248. Sasada R., Ono Y., Taniyama Y., et al. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem. Biophys. Res. Commun. 1993, 190:1173-1179.
249. Sasaki E., Arakawa T., Fujiwara Y., et al. Epiregulin stimulates proliferation of rabbit gastric cells in primary culture through autophosphorylation of the epidermal growth factor receptor. Eur. J. Pharmacol. 1997, 338:253-258.
250. Schroeder J.A., Lee D.C. Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia. J. Mammary Gland Biol. Neoplasia 1997, 2:119-129.
251. Schroeder J.A., Lee D.C. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 1998, 9:451-464.
252. Schroeder J.A., Troyer K.L., Lee D.C. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Oncogene 2000, 19:3193-3199.
253. Schuger L., Johnson G.R., Gilbride K., et al. Amphiregulin in lung branching morphogenesis: interaction with heparan, sulfate proteoglycan modulates cell proliferation. Development 1996, 122:1759-1767.
254. Schwartzbauer G., Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem. 2001, 276:35786-35793.
255. Scott J., Urdea M., Quiroga M., et al. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science 1983, 221:236-240.
256. Sehgal I., Bailey J., Hitzemann K., et al. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells. Mol. Biol. Cell. 1994, 5:339-347.
257. Seno M., Tada H., Kosaka M., et al. Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. Growth Factors 1996, 13:181-191.
258. Seroogy K.B., Han V.K., Lee D.C. Regional expression of transforming growth factor-alpha mRNA in the rat central nervous system. Neurosci. Lett. 1991, 125:241-245.
259. Sharp R., Babyatsky M.W., Takagi H., et al. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development 1995, 121:149-161.
260. Sheflin L.G., Brooks E.M., Keegan B.P., Spaulding S.W. Increased epidermal growth factor expression produced by testosterone in the submaxillary gland of female mice is accompanied by changes in poly-A tail length and periodicity. Endocrinology 1996, 137:2085-2092.
261. Shelly M., Pinkas-Kramarski R., Guarino B.C., et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 1998, 273:10496-10505.
262. Sherwin S.A., Twardzik D.R., Bohn W.H., et al. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res. 1983, 43:403-407.
263. Shi W., Fan H., Shum L., Derynck R. The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J. Cell. Biol. 2000, 148:591-602.
264. Shin T.H., Kudlow J.E. Identification and characterization of the human transforming growth factor-alpha initiator. Mol. Endocrinol. 1994, 8:704-712.
265. Shin T.H., Paterson A.J., Grant J.H., et al. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol. Cell. Biol. 1992, 12:3998-4006.
266. Shin T.H., Paterson A.J., Kudlow J.E. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53. Mol. Cell. Biol. 1995, 15:4694-4701.
267. Shing Y., Christofori G., Hanahan D., et al. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 1993, 259:1604-1607.
268. Shirakata Y., Komurasaki T., Toyoda H., et al. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem. 2000, 275:5748-5753.
269. Shoyab M., McDonald V.L., Bradley J.G., Todaro G.J. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc. Natl Acad. Sci. USA 1988, 85:6528-6532.
270. Shoyab M., Plowman G.D., McDonald V.L., et al. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989, 243:1074-1076.
271. Shum L., Reeves S.A., Kuo A.C., et al. Association of the transmembrane TGF-alpha precursor with a protein kinase complex. J. Cell. Biol. 1994, 125:903-916.
272. Shum L., Turck C.W., Derynck R. Cysteines 153 and 154 of transmembrane transforming growth factor-alpha are palmitoylated and mediate cytoplasmic protein association. J. Biol. Chem. 1996, 271:28502-28508.
273. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995, 269:234-238.
274. Strachan L., Murison J.G., Prestidge R.L., et al. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem. 2001, 276:18265-18271.
275. Sundaresan S., Roberts P.E., King K.L., et al. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology 1998, 139:4756-4764.
276. Sunnarborg S.W., Hinkle C.L., Stevenson M., et al. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 2002, 277:12838-12845.
277. Suzuki M., Raab G., Moses M.A., et al. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 1997, 272:31730-31737.
278. Sweeney C., Lai C., Riese D.J., et al. Ligand discrimination in signaling through an ErbB4 receptor homodimer. J. Biol. Chem. 2000, 275:19803-19807.
279. Tada H., Sasada R., Kawaguchi Y., et al. Processing and juxtacrine activity of membrane-anchored betacellulin. J. Cell. Biochem. 1999, 72:423-434.
280. Takagi H., Jhappan C., Sharp R., Merlino G. Hypertrophic gastropathy resembling Menetrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J. Clin. Invest. 1992, 90:1161-1167.
281. Takagi H., Sharp R., Hammermeister C., et al. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res. 1992, 52:5171-5177.
282. Tamano S., Merlino G.T., Ward J.M. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis 1994, 15:1791-1798.
283. Tamura R., Miyagawa J., Nishida M., et al. Immunohistochemical localization of Betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta. Atherosclerosis 2001, 155:413-423.
284. Tang X.B., Dallaire P., Hoyt D.W., et al. Construction of transforming growth factor alpha (TGF-alpha) phage library and identification of high binders of epidermal growth factor receptor (EGFR) by phage display. J. Biochem. (Tokyo) 1997, 122:686-690.
285. Taylor D.S., Cheng X., Pawlowski J.E., et al. Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin. Proc. Natl Acad. Sci. USA 1999, 96:1633-1638.
286. Teixido J., Gilmore R., Lee D.C., Massague J. Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-alpha. Nature 1987, 326:883-885.
287. Teixido J., Wong S.T., Lee D.C., Massague J. Generation of transforming growth factor-alpha from the cell surface by an O-glycosylation-independent multistep process. J. Biol. Chem. 1990, 265:6410-6415.
288. Temizer D.H., Yoshizumi M., Perrella M.A., et al. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 1992, 267:24892-24896.
289. Thogersen V.B., Sorensen B.S., Poulsen S.S., et al. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res. 2001, 61:6227-6233.
290. Thorne B.A., Plowman G.D. The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion. Mol. Cell. Biol. 1994, 14:1635-1646.
291. Threadgill D.W., Dlugosz A.A., Hansen L.A., et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995, 269:230-234.
292. Todaro G.J., Fryling C., De Larco J.E. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA 1980, 77:5258-5262.
293. Tokumaru S., Higashiyama S., Endo T., et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell. Biol. 2000, 151:209-220.
294. Torring N., Jorgensen P.E., Sorensen B.S., Nexo E. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res. 2000, 20:91-95.
295. Toyoda H., Komurasaki T., Ikeda Y., et al. Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development. FEBS Lett. 1995, 377:403-407.
296. Toyoda H., Komurasaki T., Uchida D., et al. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem. 1995, 270:7495-7500.
297. Toyoda H., Komurasaki T., Uchida D., Morimoto S. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem. J. 1997, 326:69-75.
298. Tricoli J.V., Nakai H., Byers M.G., et al. The gene for human transforming growth factor alpha is on the short arm of chromosome 2. Cytogenet. Cell. Genet. 1986, 42:94-98.
299. Troyer K.L., Lee D.C. Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J. Mammary Gland Biol. Neoplasia 2001, 6:7-21.
300. Troyer K.L., Luetteke N.C., Saxon M.L., et al. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. Gastroenterology 2001, 121:68-78.
301. Twardzik D.R., Ranchalis J.E., Todaro G.J. Mouse embryonic transforming growth factors related to those isolated from tumor cells. Cancer Res. 1982, 42:590-593.
302. Twardzik D.R., Sherwin S.A., Ranchalis J., Todaro G.J. Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans. J. Natl. Cancer Inst. 1982, 69:793-798.
303. Tzahar E., Pinkas-Kramarski R., Moyer J.D., et al. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 1997, 16:4938-4950.
304. Umata T., Hirata M., Takahashi T., et al. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 2001, 276:30475-30482.
305. Umeda Y., Miyazaki Y., Shiinoki H., et al. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev. Biol. 2001, 237:202-211.
306. Umekita Y., Ohi Y., Sagara Y., Yoshida H. Coexpression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast cancer patients. Int. J. Cancer 2000, 89:484-487.
307. Urena J.M., Merlos-Suarez A., Baselga J., Arribas J. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP). J. Cell. Sci. 1999, 112:773-784.
308. Vail M.E., Pierce R.H., Fausto N. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Cancer Res. 2001, 61:594-601.
309. Vaughan T.J., Pascall J.C., Brown K.D. Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem. J. 1992, 287:681-684.
310. Vecchi M., Rudolph-Owen L.A., Brown C.L., et al. Tyrosine phosphorylation and proteolysis. Pervanadateinduced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. J. Biol. Chem. 1998, 273:20589-20595.
311. Vinante F., Rigo A., Papini E., et al. Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor expression by acute myeloid leukemia cells. Blood 1999, 93:1715-1723.
312. Wang D., Kudlow J.E. Purification and characterization of TEF1, a transcription factor that controls the human transforming growth factor-alpha promoter. Biochim. Biophys. Acta 1999, 1449:50-62.
313. Wang D., Shin T.H., Kudlow J.E. Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene. J. Biol. Chem. 1997, 272:14244-14250.
314. Wang J., Mayernik L., Schultz J.F., Armant D.R. Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stagespecific activation of calcium influx by ErbB receptors in developing mouse blastocysts. Development 2000, 127:33-44.
315. Wang L.M., Kuo A., Alimandi M., et al. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc. Natl Acad. Sci. USA 1998, 95:6809-6814.
316. Wang X.J., Greenhalgh D.A., Lu X.R., et al. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas. Oncogene 1995, 10:279-289.
317. Watada H., Kajimoto Y., Miyagawa J., et al. PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes 1996, 45:1826-1831.
318. Watanabe T., Shintani A., Nakata M., et al. Recombinant human betacellulin. Molecular structure, biological activities. and receptor interaction. J. Biol. Chem. 1994, 269:9966-9973.
319. Wen D., Peles E., Cupples R., et al. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 1992, 69:559-572.
320. Wiesen J.F., Young P., Werb Z., Cunha G.R. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 1999, 126:335-344.
321. Wiley H.S., Woolf M.F., Opresko L.K., et al. Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization. J. Cell. Biol. 1998, 143:1317-1328.
322. Wong L., Deb T.B., Thompson S.A., et al. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. J. Biol. Chem. 1999, 274:8900-8909.
323. Wong R.W., Kwan R.W., Mak P.H., et al. Over-expression of epidermal growth factor induced hypospermatogenesis in transgenic mice. J. Biol. Chem. 2000, 275:18297-18301.
324. Wong S.T., Winchell L.F., McCune B.K., et al. The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 1989, 56:495-506.
325. Xian C.J., Zhou X.F. Roles of transforming growth factor-alpha and related molecules in the nervous system. Mol. Neurobiol. 1999, 20:157-183.
326. Xian C.J., Cool J.C., Howarth G.S., Read L.C. Effects of TGF-alpha gene knockout on epithelial cell kinetics and repair of methotrexate-induced damage in mouse small intestine. J. Cell. Physiol. 2002, 191:105-115.
327. Yamamoto K., Miyagawa J., Waguri M., et al. Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes 2000, 49:2021-2027.
328. Yang H., Jiang D., Li W., et al. Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells. Oncogene 2000, 19:1901-1914.
329. Yokoyama T. Inhibition of ras-dependent transformation by usnng dominant negative ras mutant N116Y. Hokkaido Igaku Zasshi 1995, 70:459-471.
330. Yoshizumi M., Kourembanas S., Temizer D.H., et al. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J. Biol. Chem. 1992, 267:9467-9469.
331. Yu W.H., Woessner J.F., McNeish J.D., Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 2002, 16:307-323.
332. Zabel B.U., Eddy R.L., Lalley P.A., et al. Chromosomal locations of the human and mouse genes for precursors of epidermal growth factor and the beta subunit of nerve growth factor. Proc. Natl Acad. Sci. USA 1985, 82:469-473.
333. Zhang D., Sliwkowski M.X., Mark M., et al. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl Acad. Sci. USA 1997, 94:9562-9567.
334. Zieske J.D., Takahashi H., Hutcheon A.E., Dalbone A.C. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest. Ophthalmol. Vis. Sci. 2000, 41:1346-1355.